Entity type
Company
Filer Snapshot
PFIZER INC
CIK 0000078003. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
290
Latest filing
01 Jun 2026
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
$238.78M
18 holdings for Q1 2026
Open portfolioLargest parsed holding
ORIC
$57.65M reported value
Open holding13D/G large stake
ORIC
31 Mar 2026 · 3.3% ownership
Open 13D/GInsider / owner context
ORIC
23 Dec 2022 · $46.16M
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 01 Jun 2026 for CIK 0000078003.
- Listed symbols
- PFE on NYSE
- Parsed SEC ownership signals
-
Parsed SEC ownership coverage
These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.
13F portfolio$238.78MQuarterly institutional holdings reported on Form 13F.
Forms 3/4/5 positions$65.57MReporting-owner positions with enough filing detail to estimate value.
Latest reported 13F value
13F$238.78MReported market value from the latest parsed Form 13F information table; this is not total assets under management.
Forms 3/4/5 position value
3/4/5$65.57MEstimated from parsed Forms 3/4/5 when filings include enough share and price data.
Largest 13F holdings
13FORIC ALLO ARVN CELC ZURA+13 more
WVE PYXS CRBU SPRO BHVN CRDF ZNTL NXTC AGMB QTTB BOLT DNA SENSLargest symbols in the latest parsed Form 13F information table.
Largest linked holdings
Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.
ORIC PYXSLargest 13F holdings
Largest symbols in the latest parsed Form 13F information table.
ORIC ALLO ARVN CELC ZURA WVE PYXS CRBU+10 more
SPRO BHVN CRDF ZNTL NXTC AGMB QTTB BOLT DNA SENSLargest active 13D stakes
Active large-stake positions disclosed in parsed Schedule 13D filings.
HLN ALLOLargest active 13G stakes
Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.
ORIC CRDF ZURA QTTB NXTCHow to read these SEC ownership signals
- Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
- Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 66 Hudson Boulevard East, New York, NY, 10001-2192
- Incorporated in
- DE
- Fiscal year end
- 31 December
Ownership signals
CIK-linked ownership evidence from parsed SEC filings.
1 signal
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Filer intelligence
What SEC filings say about PFIZER INC
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Latest parsed 13F shows $238.78M across 18 reported holdings for Q1 2026.
- Largest parsed 13F holding: ORIC at $57.65M.
- 5 recent 13D/G stake rows found; top row is ORIC at 3.3% ownership.
- Forms 3/4/5 show insider context for ORIC worth $46.16M.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Top parsed 13F holdings
Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.
Top 5 concentration
80%
Share of latest parsed 13F value represented by the visible holdings below.
Top 5 reported value
$190.55M
Compared with $238.78M total 13F value.
Top 5 net change
-$13.66M
Position-value change inside the visible top holdings only.
13F concentration map
A simple visual split of the latest parsed 13F portfolio.
Largest add: AGMB · Largest trim: ORIC
ORIC
ALLO
ARVN
CELC
ZURA
Other holdings
13D/G large-stake context
ORIC
31 Mar 2026 · Common Stock par value $0.0001 per share
NXTC
31 Dec 2025 · Common Stock par value $0.001 per share
ALLO
06 Nov 2025 · Common Stock, par value $0.001 per share (the "Common Stock")
HLN
21 Mar 2025 · Ordinary Shares, nominal value GBP0.01 per share
Forms 3/4/5 insider context
ORIC
23 Dec 2022 · 10% owner
PYXS
17 Mar 2023 · 10% owner
CERE
01 Aug 2024
ZURA
20 Mar 2023 · 10% owner
Latest update
What changed recently for PFIZER INC
Latest Schedule 13D/G period: 31 Mar 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
12 May 2026
Page type
Filer profile
Latest period
31 Mar 2026
Schedule 13D/G context is visible from filings filed on 12 May 2026.
Benchmark Context
Benchmark context for this company
PFIZER INC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest Schedule 13D/G period: 31 Mar 2026. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 05 May 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0000078003 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
290
First seen
29 Dec 2023
Latest filing
01 Jun 2026
Entity
Company
Observed form types
10-K
10-Q
13F-HR
3
3/A
4
4/A
SCHEDULE 13D/A
SCHEDULE 13G/A
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 290 SEC filings for PFIZER INC.
4
4 filing
- Filing date
- 01 Jun 2026
- Reporting date
- 29 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 May 2026
- Reporting date
- 15 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SCHEDULE 13G/A
SCHEDULE 13G/A filing
- Filing date
- 12 May 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
13F-HR
13F-HR filing
- Filing date
- 12 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
10-Q filing
- Filing date
- 05 May 2026
- Reporting date
- 29 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing